175 related articles for article (PubMed ID: 1362592)
1. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
Horiguchi J; Nishimatsu O
Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592
[TBL] [Abstract][Full Text] [Related]
2. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
3. A double-blind comparison of clonazepam and placebo in the treatment of neuroleptic-induced akathisia.
Pujalte D; Bottaï T; Huë B; Alric R; Pouget R; Blayac JP; Petit P
Clin Neuropharmacol; 1994 Jun; 17(3):236-42. PubMed ID: 9316669
[TBL] [Abstract][Full Text] [Related]
4. Successful clonazepam treatment of neuroleptic-induced akathisia in older adolescents and young adults: a double-blind, placebo-controlled study.
Kutcher S; Williamson P; MacKenzie S; Marton P; Ehrlich M
J Clin Psychopharmacol; 1989 Dec; 9(6):403-6. PubMed ID: 2574191
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment with clonazepam for neuroleptic-induced akathisia.
Horiguchi J; Nishimatsu O; Inami Y
Acta Psychiatr Scand; 1989 Jul; 80(1):106-7. PubMed ID: 2569804
[TBL] [Abstract][Full Text] [Related]
6. Placebo response in refractory tardive akathisia.
Remington G; Fornazzari L; Sethna R
Can J Psychiatry; 1993 May; 38(4):248-50. PubMed ID: 8100184
[TBL] [Abstract][Full Text] [Related]
7. Handedness as a risk factor for neuroleptic-induced movement disorders.
Brown KW; White T; Anderson F; McGilp R
Biol Psychiatry; 1992 Apr; 31(7):746-8. PubMed ID: 1350923
[No Abstract] [Full Text] [Related]
8. The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy.
Manos N; Gkiouzepas J; Logothetis J
Am J Psychiatry; 1981 Feb; 138(2):184-8. PubMed ID: 6109453
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the need for prophylactic antiparkinsonian medication in psychotic patients treated with neuroleptics.
Manos N; Lavrentiadis G; Gkiouzepas J
J Clin Psychiatry; 1986 Mar; 47(3):114-6. PubMed ID: 2869027
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of antiparkinson drug withdrawal.
Jellinek T; Gardos G; Cole JO
Am J Psychiatry; 1981 Dec; 138(12):1567-71. PubMed ID: 6118066
[TBL] [Abstract][Full Text] [Related]
11. No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia.
Hansen L; Jones RM; Kingdon D
J Psychopharmacol; 2004 Sep; 18(3):384-7. PubMed ID: 15358982
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of drug-induced akathisia: Part I. Acute akathisia.
Sachdev P
Schizophr Bull; 1995; 21(3):431-49. PubMed ID: 7481574
[TBL] [Abstract][Full Text] [Related]
13. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
Bezchlibnyk-Butler KZ; Remington GJ
Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
[TBL] [Abstract][Full Text] [Related]
14. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
Metzer WS; Paige SR; Newton JE
Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
[TBL] [Abstract][Full Text] [Related]
15. Relationship of neuroleptic-induced akathisia to drug-induced parkinsonism.
Sandyk R; Kay SR
Ital J Neurol Sci; 1990 Oct; 11(5):439-42. PubMed ID: 1980270
[TBL] [Abstract][Full Text] [Related]
16. Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects.
Tugg LA; Desai D; Prendergast P; Remington G; Reed K; Zipursky RB
Schizophr Res; 1997 May; 25(1):71-8. PubMed ID: 9176929
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of tardive dystonia with clozapine and clonazepam.
Shapleske J; Mickay AP; Mckenna PJ
Br J Psychiatry; 1996 Apr; 168(4):516-8. PubMed ID: 8730951
[TBL] [Abstract][Full Text] [Related]
18. Dysphagia: a rare form of dyskinesia?
Nieves JE; Stack KM; Harrison ME; Gorman JM
J Psychiatr Pract; 2007 May; 13(3):199-201. PubMed ID: 17522565
[No Abstract] [Full Text] [Related]
19. Periodic limb movement disorder in neuroleptic-induced akathisia.
Nishimatsu O; Horiguchi J; Inami Y; Sukegawa T; Sasaki A
Kobe J Med Sci; 1997 Oct; 43(5):169-77. PubMed ID: 9642972
[TBL] [Abstract][Full Text] [Related]
20. Cyproheptadine treatment in neuroleptic-induced akathisia.
Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
